We believe new approaches in #immunosuppression can play a key role in addressing the organ shortage crisis. In this Men's Health Mag article, Nate Robinson shares challenges he has faced as one of the 100K people in the US waiting for a #KidneyTransplant: menshealth.com/health/a610863…

We are dedicated to supporting the health of people who need an #OrganTransplant. Learn more about our focus on developing new therapeutic solutions in #immunosuppression that may help preserve and protect transplanted kidneys:  eledon.com/overview/focus/

Guided by our mission to achieve #OneTransplantForLife, we initiated our Phase 2 BESTOW clinical trial to support innovative research focused on the potential to increase #KidneyTransplant function and longevity. Learn more: bestowstudy.com

Waiting lists for #KidneyTransplants continue to grow longer, making the need for new #immunosuppressant solutions to support #OrganTransplant function increasingly urgent. National Kidney Foundation shares insights on challenges to overcome to achieve #TransplantsForAll: kidney.org/transplantation

Stories from the #transplant community drive our work. When Chazley shared her #KidneyHealth issues with her classmates, her professor was inspired to register as a living donor – a decision that would ultimately change both their lives: donatelife.net/stories-of-hop… Donate Life America

We are pleased to announce the enrollment of the 80th participant in our ongoing Phase 2 BESTOW clinical trial assessing a treatment for the prevention of rejection in #KidneyTransplantation. For details, see our press release: ir.eledon.com/news-releases/… $ELDN

Our team includes experts in #immunology who are leveraging their knowledge of the CD40L pathway to develop novel therapies with the potential to protect transplanted organs and prevent rejection. Read more about our science here: eledon.com/science/mechan…

August marks 25 years since basketball legend Sean Elliott received a #KidneyTransplant. From learning he had #KidneyDisease to his #transplant experience, he took the time to share his story with our CEO David-Alexandre Gros. Hear his inspiring story: vimeo.com/993660087

In a discussion with our CEO David-Alexandre Gros, Sean Elliott talks about how the symptoms of #KidneyDisease affected his health during his professional basketball career. Watch more to hear his story and learn about the real-life impact of kidney disease: eledon.com/overview/patie…

In this video, Sean Elliott reflects on the heroic step his brother took by donating one of his kidneys after learning that he was a compatible match. Watch more from his discussion with David-Alexandre Gros to hear insights about the impact of #OrganDonation: eledon.com/overview/patie…

After his #KidneyTransplant, Sean Elliott saw that he had the opportunity to be a voice for others. His story has helped so many people learn about #KidneyTransplantation so they can face this challenge with information and encouragement. Watch more: eledon.com/overview/patie…

In this Inside Precision Medicine article, $ELDN CEO David-Alexandre Gros shares insights on #tegoprubart & our research to advance novel #immunosuppressants that may be able to support the prevention of pancreatic islet cell #transplant rejection in patients with type 1 #diabetes insideprecisionmedicine.com/topics/precisi…

Today we reported recent business highlights for the second quarter 2024. For details, see our press release: ir.eledon.com/news-releases/… $ELDN

In this video, Sean Elliott discusses his transition from athlete to mentor for the #transplant community. His goal is to help more people be proactive and informed about issues associated with #KidneyTransplant including #immunosuppression. Watch more: eledon.com/overview/patie…

As we work to advance innovation in #immunosuppression for #transplant recipients, we recognize the urgent need to address barriers limiting access to #KidneyTransplantation. This #NMDAM2024, learn about National Kidney Foundation’s efforts to achieve #KidneyEquityForAll: kidneyequityforall.org $ELDN

Sean Elliott is dedicated to learning about research that can lead to new & better #immunosuppressant therapies for #transplant recipients. Watch his discussion with David-Alexandre Gros about advances in medicine that can make a positive difference: eledon.com/overview/patie… Sean Elliott

In our Phase 2 BESTOW study, we're assessing a potential #immunosuppressant solution that may be able to support the prevention of rejection in #KidneyTransplantation. Learn about our research that is guided by our mission to achieve #OneTransplantForLife: bestowstudy.com/$ELDN

Sean Elliott highlights a key issue in #KidneyTransplant – the therapies used to support #immunosuppression can be toxic to the kidneys they are supposed to protect. Watch more from his discussion with our CEO David-Alexandre Gros: eledon.com/overview/patie… Sean Elliott

Great article by Science Magazine exploring the history of CD40L antagonists and the key research advances that are driving new opportunities in #immunosuppression therapy, including developments related to our investigational treatment. Read more: science.org/doi/full/10.11… $ELDN

Today we announced the completion of enrollment in our Phase 2 BESTOW clinical trial assessing an investigational therapy for the prevention of organ rejection in patients undergoing #KidneyTransplantation. For details, see our press release: ir.eledon.com/news-releases/… $ELDN